Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, Nishiwaki T, Kawasoe T, Ishiguro H, Fujita M, Tokino T, Sasaki Y, Imaoka S, Murata M, Shimano T, Yamaoka Y, Nakamura Y

AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.

Nat Genet 24:245-50 (2000)
DOI:10.1038/73448

Salahshor S, Woodgett JR

The links between axin and carcinogenesis.

J Clin Pathol 58:225-36 (2005)
DOI:10.1136/jcp.2003.009506

Taniguchi K, Roberts LR, Aderca IN, Dong X, Qian C, Murphy LM, Nagorney DM, Burgart LJ, Roche PC, Smith DI, Ross JA, Liu W

Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas.

Oncogene 21:4863-71 (2002)
DOI:10.1038/sj.onc.1205591

Mazzoni SM, Fearon ER

AXIN1 and AXIN2 variants in gastrointestinal cancers.

Cancer Lett 355:1-8 (2014)
DOI:10.1016/j.canlet.2014.09.018

Li J, Quan H, Liu Q, Si Z, He Z, Qi H

Alterations of axis inhibition protein 1 (AXIN1) in hepatitis B virus-related hepatocellular carcinoma and overexpression of AXIN1 induces apoptosis in hepatocellular cancer cells.

Oncol Res 20:281-8 (2013)
DOI:10.3727/096504013X13639794277608